Han Wook Choi - 30 Sep 2024 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Financial Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
30 Sep 2024
Net transactions value
$0
Form type
4
Filing time
02 Oct 2024, 16:17:33 UTC
Next filing
05 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Employee Stock Option (right to buy) Award $0 +400,000 $0.000000 400,000 30 Sep 2024 Common Stock 400,000 $0.7000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares underlying the option vest on September 30, 2025, with the remainder vesting in equal monthly installments at the end of the each month thereafter over 3 years, in each case subject to the Reporting Person's continued service as of each such date.